Brief: CNS Pharmaceuticals Completes Manufacturing Of Berubicin For Phase 2 Clinical Trial

CNS Pharmaceuticals

29/10/2020 12:17

Oct 29 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS COMPLETES MANUFACTURING OF BERUBICIN
FOR
PHASE 2 CLINICAL TRIAL
    * CNS PHARMACEUTICALS - REMAINS POISED TO FILE IND AND
INITIATE
ITS PHASE 2 U.S. CLINICAL TRIAL FOR BERUBICIN ON ITS ANTICIPATED
TIMELINE
    * CNS PHARMACEUTICALS - REMAIN POSITIONED TO INITIATE A U.S.
PHASE
2 TRIAL FOR BERUBICIN DURING Q1 OF 2021

Source text for Eikon:  ID:nPn4kPd6Za 
Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))